You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 166 No. 15, Aug 14/28, 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Diabetes Mellitus
 •Neurology
 •Nutritional and Metabolic Disorders, Other
 •Treatment Adherence
 •Alert me on articles by topic

The Dogma of "Tight Control": Beyond the Limits of Evidence—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In reply

Finucane asks whether the failure of primary care providers to intensify therapy for patients with diabetes who have high glucose levels—"clinical inertia"—might reflect the view that tight glycemic control has not yet been proven to benefit patients with type 2 diabetes mellitus. Moreover, providers rarely questioned the hemoglobin A1c goal of lower than 7.0% during performance feedback sessions, and intensification at all levels of glucose improved with the Improving Primary Care of African Americans With Diabetes (IPCAAD) intervention.1

More broadly, we are concerned about "RCTomyopia" (belief that clinical action can be justified only by randomized, controlled trials) and "evidence-based paralysis" (unwillingness to take action without incontrovertible proof from controlled trials). We believe that responsible physicians and patients should make decisions based on the best available evidence—including cell and animal studies, observational studies, and controlled trials, if available—and that the strengths and weaknesses of the findings with each approach . . . [Full Text of this Article]


AUTHOR INFORMATION
David C. Ziemer, MD; Lawrence S. Phillips, MD


RELATED LETTER

The Dogma of "Tight Control": Beyond the Limits of Evidence
Thomas E. Finucane
Arch Intern Med. 2006;166(15):1671-1672.
EXTRACT | FULL TEXT  

RELATED ARTICLES

An Intervention to Overcome Clinical Inertia and Improve Diabetes Mellitus Control in a Primary Care Setting: Improving Primary Care of African Americans With Diabetes (IPCAAD) 8
David C. Ziemer, Joyce P. Doyle, Catherine S. Barnes, William T. Branch, Jr, Curtiss B. Cook, Imad M. El-Kebbi, Daniel L. Gallina, Paul Kolm, Mary K. Rhee, and Lawrence S. Phillips
Arch Intern Med. 2006;166(5):507-513.
ABSTRACT | FULL TEXT  

Hypoglycemia in Patients With Type 2 Diabetes Mellitus
Christopher D. Miller, Lawrence S. Phillips, David C. Ziemer, Daniel L. Gallina, Curtiss B. Cook, and Imad M. El-Kebbi
Arch Intern Med. 2001;161(13):1653-1659.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.